Referring to an order issued by the Municipal Corporation of Delhi on Wednesday, the sources sa…

Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfi…

More than half of the stock market's post-Trump-election rally has been erased.

There is currently no approved mpox vaccine in China. Globally, a few vaccines have been approv…

AstraZeneca made headlines on Tuesday as it initiated the global withdrawal of its COVID-19 vaccine…

AstraZeneca has announced that the vaccine was being removed from markets for commercial reasons.

Stock indexes tanked Thursday as new data shows jobless claims are on the rise while manufacturing …

Indexes rose Thursday as investors reacted to a surprisingly strong increase in retail sales and lo…

Yang Xiaoming was kicked from the National People's Congress earlier this month. He was in charge o…

"If we have to make a brand new vaccine, I think that's going to be early 2022 before that's really…

The drugmaker expects 2022 revenue of $98 billion to $102 billion, which fell below analyst expecta…

"It's time for these pharmaceutical companies to share their vaccines with the world and start cont…

The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…

Investors ditched stocks and ran for safe assets like bonds after Moderna's chief executive said ne…

Vaccinating the world would cost about $50 billion, the OECD says. That could be easily paid for fr…

Moderna now anticipates full-year production between 700 million and 800 million doses, a downgrade…

More than 5,000 people have pledged about 21 bitcoin in satoshis to the HonkHonkHodl campaign via c…

An analysis from Indeed Hiring Lab found that the share of job postings requiring a COVID-19 vaccin…

Pfizer and Valneva have said their vaccine produced immunity in phase 2 trials. If phase 3 pans out…

The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …